Desmopressin (DDAVP) induces NO production in human endothelial cells via V2 receptor- and cAMP-mediated signaling.

Kaufmann, J E; Iezzi, M; Vischer, U M

Kaufmann, J E; Iezzi, M; Vischer, U M.

Affiliation

Kaufmann JE; Division of Clinical Biochemistry, and Department of Geriatric Medicine, Geneva, Switzerland.

J Thromb Haemost ; 1(4): 821-8, 2003 Apr.

Article in En | MEDLINE | ID: mdl-12871421

Subject(s)

Deamino Arginine Vasopressin/pharmacology; Endothelium, Vascular/cytology; Nitric Oxide/biosynthesis; Receptors, Vasopressin/metabolism; Signal Transduction/drug effects; Cyclic AMP/physiology; Enzyme Activation/drug effects; Humans; Kidney/metabolism; Muscle, Skeletal/metabolism; Nitric Oxide Synthase/drug effects; Nitric Oxide Synthase/metabolism; Nitric Oxide Synthase Type III; Receptors, Vasopressin/physiology; Tissue Distribution

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Endothelium, Vascular / Signal Transduction / Receptors, Vasopressin / Deamino Arginine Vasopressin / Nitric Oxide Limits: Humans Language: En Journal: J Thromb Haemost Journal subject: HEMATOLOGIA Year: 2003 Document type: Article Affiliation country: Switzerland Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links